Strateos company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Series B | Alive

Total Raised


Last Raised

$56M | 1 yr ago

About Strateos

Strateos automates chemistry, biology, and tissue analysis into closed loop robotic labs that accelerate drug discovery programs.

Strateos Headquarter Location

3565 Haven Ave Suite 3

Menlo Park, California, 94025,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Strateos

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Strateos in 1 CB Insights research brief, most recently on Feb 21, 2022.

Expert Collections containing Strateos

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Strateos is included in 2 Expert Collections, including Game Changers 2018.


Game Changers 2018

70 items


Digital Health

13,075 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Strateos Patents

Strateos has filed 3 patents.

The 3 most popular patent topics include:

  • Histology
  • Staining
  • Biological research institutes
patents chart

Application Date

Grant Date


Related Topics




Biological research institutes, Histology, Pathology, Staining, Microscopy


Application Date


Grant Date



Related Topics

Biological research institutes, Histology, Pathology, Staining, Microscopy



Latest Strateos News

People, not projects, but what about scientific tools?

Feb 8, 2022

Image Credits: Amy / Flickr / Creative Commons The software landscape for bio laboratory work has improved over the past decade. Companies like Benchling and Strateos (we’re proud backers of both) have brought the ease of use of consumer software to the wet lab, allowing for easier management of the rapidly accelerating quantities of data that scientists produce these days. Yet the rest of the landscape is still a kluge, and it’s slowing progress in the field. Lux’s Zavain Dar passed along a New Science article by Elliot Hershberg, a Stanford PhD student, explaining “ How Software in the Life Sciences Actually Works (And Doesn’t Work) .” Hershberg argues that despite the critical need for better software and data management tools, major scientific funding agencies almost entirely ignore them. The result is that principal investigators and graduate students share their code online, code that has no long-term funding to ensure its maintainability — even when it becomes critical to lab workflows. As Hershberg concludes, “The short-term panacea of abundant free software in the life sciences has allowed funding agencies to carry on with the existing investigator-based grant model, without ever rigorously evaluating how to fund software development directly.” Software projects do not make “great” science work. It’s hard to get citations, it’s hard to build a track record, it’s hard to submit for tenure with code printed and stapled together. And yet, software is — quite literally — the operating system that empowers all of the biological sciences to continue functioning. While there are a few lucrative veins here for VC-funded software innovation (and we are always on the lookout for these opportunities! ), the reality is that much of lab software doesn’t make scalable commercial sense. Open-source approaches are going to work better, presuming that they can be maintained. Nadia Eghbal, who was funded by the Ford Foundation to investigate open-source sustainability, wrote a great book called “ Working in Public: The Making and Maintenance of Open Source Software ” that cataloged the ways to make such work more visible and viable. Sam Arbesman has been quite focused on finding new ways to design scientific funding institutions. But we need to do more than just find better ways to fund the right people — we also need to make sure the systems that underpin the great scientific work happening in the twenty-first century get their due as well.

Strateos Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Strateos Rank

  • Where is Strateos's headquarters?

    Strateos's headquarters is located at 3565 Haven Ave, Menlo Park.

  • What is Strateos's latest funding round?

    Strateos's latest funding round is Series B.

  • How much did Strateos raise?

    Strateos raised a total of $98.52M.

  • Who are the investors of Strateos?

    Investors of Strateos include Data Collective, Lux Capital, Mack & Co., Black Diamond Ventures, Eli Lilly and Company and 18 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.